NATURAL HISTORY OF BLADDER-SPARING THERAPY IN PATIENTS WITH BCG-UNRESPONSIVE DISEASE; RESULTS FROM A LARGE MULTI-CENTER COHORT
Jacob Taylor(The University of Texas Southwestern Medical Center), William C. Huang(NYU Langone Health), Gary K. Steinberg(Palo Alto University), Facundo Davaro(Moffitt Cancer Center), Jeffrey Howard(The University of Texas Southwestern Medical Center), Elizabeth Dyer(Penn State Milton S. Hershey Medical Center), Ashish M. Kamat(The University of Texas MD Anderson Cancer Center), Stephen Harrington(Penn State Milton S. Hershey Medical Center), M. Roumiguié(Institut universitaire du cancer de Toulouse Oncopole), Yair Lotan(Southwestern Medical Center), Ian M. McElree(Vanderbilt University Medical Center), Seth P. Lerner(Baylor College of Medicine), Peter C. Black(University of British Columbia), Roger Li(Unknown), Anna J. Black(University of British Columbia), Pratik Kanabur(Carilion Clinic), Wei Shen Tan, Solomon L. Woldu(The University of Texas Southwestern Medical Center), Vignesh T. Packiam(Rutgers, The State University of New Jersey), Drupad Annapureddy(The University of Texas Southwestern Medical Center), Jay D. Raman(Penn State Milton S. Hershey Medical Center), Michael A. O’Donnell(University of Iowa Health Care), Mark A. Preston(Brigham and Women's Hospital), Kendrick Yim(Brigham and Women's Hospital)
Cited by 1
Related Papers
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|793
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study
|The Lancet Oncology|2021|532
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)
|World Journal of Urology|2016|471
Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors
|Science Translational Medicine|2017|427